🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GC004 is a Phase I trial to evaluate the safety and the immune responses of...
Status
Unknown
Location
Multiple Locations
Start Date
2020-07
Trial ID
NCT04428073
Treatments Being Tested
The investigators aim to test the hypothesis that a microbiome-changing die...
Status
Recruiting
Location
Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences
Start Date
2022-03-08
Trial ID
NCT05353504
Treatments Being Tested
Some carbohydrates (complex sugars) which are found in grains, fruit and ve...
Status
Completed
Location
Sir Peter Mansfield Magnetic Resonance Centre
Start Date
2013-10
Trial ID
NCT01963364
Treatments Being Tested
This study will determine the immunogenicity of Spikogen in vaccine naïve i...
Status
Completed
Location
ARASMI
Start Date
2022-08-15
Trial ID
NCT05279456
Treatments Being Tested
The rise in the prevalence of type 2 diabetes is related to recent lifestyl...
Status
Completed
Location
Imperial College London
Start Date
2011-03
Trial ID
NCT01841073
Recombinant hemagglutinin has been shown to induce protective neutralising ...
Status
Completed
Location
Flinders University
Start Date
2015-07
Trial ID
NCT02335164
Treatments Being Tested
This is a phase III, randomized, two-armed, double-blind, placebo-controlle...
Status
Completed
Location
Espinas Palace Hotel
Start Date
2021-08-07
Trial ID
NCT05005559
Treatments Being Tested
The purpose of the study is to assess the effectiveness of Spikogen vaccine...
Status
Completed
Location
ARASMI
Start Date
2022-09-07
Trial ID
NCT05542862
Treatments Being Tested
This is a study to test a new vaccine (Covax-19) against COVID-19. COVID-19...
Status
Completed
Location
PARC,
Start Date
2020-06-30
Trial ID
NCT04453852
Treatments Being Tested